Host genetics and cellular immunity

CONTENT

Gut Microbiota Linked to Sexual Preference and HIV Infection
http://dx.doi.org/10.1016/j.ebiom.2016.01.032
HighlightsThe fecal microbiota of gay men in Europe is systematically richer and has a distinct composition.HIV-1 infection is...
Alternative Effector-Function Profiling Identifies Broad HIV-Specific T-Cell Responses in Highly...
Marta Ruiz-Riol et al. Alternative effector-function profiling identifies broad HIV-specific T-cell responses in highly HIV-exposed individuals who remain ininfected. Journal of Infectious Diseases. 2014. PMID 25249264
The characterization of host immune responses to human immunodeficiency virus (HIV) in HIV controllers and individuals with high...
Increased expression of SAMHD1 in a subset of HIV-1 elite controllers
Riveira-Muñoz E, Ruiz A, Pauls E, Permanyer M, Badia R, Mothe B, Crespo M, Clotet B, Brander C, Ballana E, Esté JA. J Antimicrob Chemother. 2014 Jul 25. pii: dku276
Objectives: SAMHD1 and the CDKN1A (p21) cyclin-dependent kinase inhibitor have been postulated to mediate HIV-1 restriction in...
Cell Cycle Control and HIV-1 Susceptibility Are Linked by CDK6-Dependent CDK2 Phosphorylation of...
Eduardo Pauls et al. J Immunol. 2014 Jul 11. pii: 1400873
Proliferating cells are preferentially susceptible to infection by retroviruses. Sterile α motif and HD domain-containing...

14th European Meeting on HIV & Hepatitis 2016
25.05.16
Roma Eventi – Fontana di Trevi Conference CentrePiazza della Pilotta, 4. This meeting was started 15 years ago with the objective to...
07.03.16 - 07.03.16
EYE Catalunya
Caixa Forum Barcelona. Av. Francesc Ferrer i Guàrdia, 6-8.
20h

EYECatalunya, plataforma creada per...

More information
22.02.16 - 25.02.16
CROI 2016 | Conference on Retroviruses and Opportunistic Infections
Hynes Convention Center. Boston, Massachusetts.

The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic,...

More information

FP7-HEALTH 602570 - iHIVARNA: Therapeutic TriMix / mRNA based Vaccine in Chronic HIV-1 Infected Patients Receiving...
Financing entity: European Commission. FP7-HEALTH
Participant entities: Institut de Recerca de la Sida IrsiCaixa, Vrije Universiteit Brusselbelgique-België, Erasmus Universitair Medisch Centrum Rotterdam, Asphalion, Etherna, Synapse Research Management Partners, Prins Leopold Instituut Voor Tropische Geneeskunde

Destacados